The Drugging of the Americas : How Multinational Drug Companies Say One Thing about Their Products to Physicians in the United States, and Another Thing to Physicians in Latin America

個数:
  • ポイントキャンペーン

The Drugging of the Americas : How Multinational Drug Companies Say One Thing about Their Products to Physicians in the United States, and Another Thing to Physicians in Latin America

  • 提携先の海外書籍取次会社に在庫がございます。通常3週間で発送いたします。
    重要ご説明事項
    1. 納期遅延や、ご入手不能となる場合が若干ございます。
    2. 複数冊ご注文の場合は、ご注文数量が揃ってからまとめて発送いたします。
    3. 美品のご指定は承りかねます。

    ●3Dセキュア導入とクレジットカードによるお支払いについて
  • 【入荷遅延について】
    世界情勢の影響により、海外からお取り寄せとなる洋書・洋古書の入荷が、表示している標準的な納期よりも遅延する場合がございます。
    おそれいりますが、あらかじめご了承くださいますようお願い申し上げます。
  • ◆画像の表紙や帯等は実物とは異なる場合があります。
  • ◆ウェブストアでの洋書販売価格は、弊社店舗等での販売価格とは異なります。
    また、洋書販売価格は、ご注文確定時点での日本円価格となります。
    ご注文確定後に、同じ洋書の販売価格が変動しても、それは反映されません。
  • 製本 Paperback:紙装版/ペーパーバック版/ページ数 168 p.
  • 言語 ENG
  • 商品コード 9780520329867
  • DDC分類 615.7042098

Full Description

The Drugging of the Americas examines the stark differences in how multinational pharmaceutical companies present their products to physicians in the United States versus Latin America. The study highlights how drug companies provide detailed, rigorous, and well-regulated information to U.S. physicians through FDA-approved sources like the Physicians' Desk Reference (PDR), ensuring claims about efficacy, contraindications, and side effects are based on scientific evidence. In contrast, the promotional materials in Latin America, where many of these drugs are also marketed, often gloss over warnings, exaggerate benefits, and lack the same level of regulatory oversight. The book compares the drug information provided in several Latin American countries, showing how local publications such as the Diccionario de Especialidades Farmacéuticas and Index Terapéutico Moderno often present biased or incomplete information.

The study underscores the global issue of drug misuse, noting that over-the-counter availability of prescription medications in many Latin American countries contributes to this problem. The discrepancies in drug labeling and promotion are not limited to the developing world but also occur in advanced economies, with similar ethical and clinical concerns in both regions. The book stresses that while it does not critique the competence of physicians in either the U.S. or Latin America, it focuses on the inadequacies of drug information and the influence of pharmaceutical companies on medical practice. By documenting these differences, The Drugging of the Americas calls attention to the broader implications of pharmaceutical marketing on global health practices.

This title is part of UC Press's Voices Revived program, which commemorates University of California Press's mission to seek out and cultivate the brightest minds and give them voice, reach, and impact. Drawing on a backlist dating to 1893, Voices Revived makes high-quality, peer-reviewed scholarship accessible once again using print-on-demand technology. This title was originally published in 1976.

最近チェックした商品